Vitamin D: Can It Prevent or Slow Cancer?

0

One way people can get vitamin D is by consuming foods including fatty fish, fish liver oil, and eggs, as well as milk, juices, and breakfast cereals to which the vitamin is added.

Vitamin D may prevent or slow some types of cancer, according to some intriguing studies. However, the evidence is not yet definitive, and no recommendations currently exist on taking extra vitamin D to prevent cancer.

Vitamin D is a nutrient that helps the body use calcium and phosphorus to build bones and teeth. People can get it through sun exposure, which causes the skin to manufacture it; by consuming foods including fatty fish, fish liver oil, and eggs, as well as milk, juices, and breakfast cereals to which the vitamin is added; and by taking dietary supplements.

Some experiments have shown that vitamin D can slow the growth of cancer cells, stimulate cell death, reduce blood vessel growth to tumors, decrease inflammation, and stimulate the body’s immune system.

Some research studies have also found connections between vitamin D levels in a person’s blood and their cancer risk. The strongest evidence to date comes from studies of vitamin D and colorectal cancer. In 2015, Dana-Farber investigators reported that patients with metastatic colorectal cancer who had high vitamin D levels prior to treatment with chemotherapy and targeted drugs survived longer, on average, than patients with lower levels. In this study, patients with the highest vitamin D blood levels survived for a median of 32.6 months, compared to 24.5 months for patients with the lowest levels.

One way people can get vitamin D is by taking dietary supplements.

One way people can get vitamin D is by taking dietary supplements.

Another Dana-Farber study, published in 2008, found that colon cancer patients who had the highest levels of vitamin D had a lower mortality rate than those with the lowest blood levels of the vitamin. The research involved 304 participants, all of whom had their vitamin D blood levels measured at least two years prior to their diagnosis.

But the overall picture is still complicated, with many uncertainties. A 2010 report from the Vitamin D Pooling Project of Rarer Cancers failed to find a link between vitamin D blood levels and the risk of developing seven uncommon cancers – endometrial, esophageal, stomach, ovarian, pancreatic, and kidney cancer, and Hodgkin lymphoma.

Some cancer patients are now being treated with high doses of vitamin D in randomized clinical trials to look for evidence of vitamin D’s benefits. A trial led by Kimmie Ng, MD, PhD, and other Dana-Farber researchers tested 139 patients with metastatic colon cancer, who received standard drug therapy and were then randomized to receive either high doses of vitamin D – 8,000 international units (IU) daily for two weeks, followed by 4,000 IU daily – or 400 IU daily, which is the amount found in multivitamin pills. Ng reported that patients receiving the high doses of vitamin D went 13.1 months before the disease progressed, compared to 11.2 months in the control arm patients. “In the world of metastatic colon cancer, this difference is significant,” she said.

Kimmie Ng, MD, MPH.

Kimmie Ng, MD, MPH.

Ng and her colleagues collected blood samples from the patients and are analyzing them to see if they can identify an optimal vitamin D level in the blood.

Other studies have been aimed at prevention, rather than treatment. One research study did not find a lower incidence of colorectal cancer in women who took vitamin D and calcium supplements for seven years versus women in a comparison group. However, the supplements only contained 400 IU of the vitamin, which could account for the lack of a demonstrated effect, and compliance with the prescribed vitamin D supplements was low. Another research study, in which older women were randomized to receive 2,000 IU of vitamin D and 1,500 milligrams of calcium daily or a placebo, did not find a significantly lower risk of all types of cancer in four years of follow-up.

A large and important prevention study called VITAL began in 2010 under the direction of scientists at Brigham and Women’s Hospital. It is investigating whether taking daily dietary supplements of vitamin D (2,000 IU) or omega-3 fatty acids reduces the risk of cancer, heart disease, and stroke.  The ongoing study involves 25,874 men and women in the United States.

The current recommended dietary allowance (RDA) for children and adults ages one to 70 (including pregnant and breastfeeding women) is 600 IU. For men and women ages 71 and older, the RDA is 800 IU.

Keep in mind that too much vitamin D can be harmful. The safe upper intake level of vitamin D for adults and children older than eight is 4,000 IU per day according to the most recent Institute of Medicine guidelines.

Learn more from the nutrition experts at Dana-Farber

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.